| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MRNA | Common Stock | Award | $0 | +5,734 | +0.4% | $0.000000 | 1,449,880 | 12 Feb 2025 | Direct | F1 |
| transaction | MRNA | Common Stock | Tax liability | $85,707 | -2,771 | -0.19% | $30.93 | 1,447,109 | 12 Feb 2025 | Direct | F2 |
| holding | MRNA | Common Stock | 4,116 | 12 Feb 2025 | By Valhalla, LLC | ||||||
| holding | MRNA | Common Stock | 151,933 | 12 Feb 2025 | By Trust | F3 |
| Id | Content |
|---|---|
| F1 | The reported transaction is the vesting of performance-based restricted stock units granted to the reporting person on March 1, 2022 (the "2022 PSUs"). |
| F2 | Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vesting of the 2022 PSUs. |
| F3 | These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. |